Directory  |   Consumers  |   FAQ  

NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

New Publication: Reaksi Drug Safety News - July 2016

Hits: 9839

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive
 

REAKSI Drug Safety News,

No. 30 ,July 2016

 

  • Concomitant Use of Spironolactone and Renin-Angiotensin System Drugs in Heart Failure: Risk of Potentially Fatal Hyperkalaemia
  • Noxafil® (posaconazole): Tablet and Oral Suspension Not Interchangeable

 



 		  
  DOWNLOAD PDF

 

 

 

Rating:
( 1 Rating )

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

More Links

Our Location

Public Enquiry

Privacy & Policy

Archives

More Links

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product StatusNPRA Product Status

NPRA Product Status

Site Last Modified

  • Last Modified: Thursday 21 November 2024, 14:55:22.

Online Services

Search

Main Menu English

Choose Your Language